| MEPS HC 254A CODEBOOK |
| 2024 PRESCRIBED MEDICINES |
| DATE: June 4, 2026 |
| Variable Name: |
TC1S1 |
| Description: |
MULTUM THERAPEUTIC SUB-CLASS #1 FOR TC1 |
| Format: |
3.0 |
| Type: |
NUM |
| Start: |
440 |
| End: |
442 |
|
|
|
| -15 CANNOT BE COMPUTED |
4,601 |
75,419,189 |
| -1 INAPPLICABLE |
7,234 |
108,332,123 |
| 2 AMEBICIDES |
146 |
2,324,238 |
| 4 ANTIFUNGALS |
398 |
6,048,458 |
| 5 ANTIMALARIAL AGENTS |
981 |
14,516,155 |
| 7 ANTIVIRAL AGENTS |
1,227 |
21,034,969 |
| 9 CEPHALOSPORINS |
867 |
13,404,964 |
| 11 MACROLIDE DERIVATIVES |
693 |
11,841,831 |
| 12 MISCELLANEOUS ANTIBIOTICS |
2 |
35,857 |
| 13 PENICILLINS |
2,028 |
35,733,066 |
| 14 QUINOLONES |
302 |
4,421,358 |
| 15 SULFONAMIDES |
311 |
4,636,825 |
| 17 URINARY ANTI-INFECTIVES |
370 |
5,500,003 |
| 19 ANTIHYPERLIPIDEMIC AGENTS |
16,482 |
231,858,687 |
| 23 ANTIMETABOLITES |
342 |
4,711,348 |
| 24 ANTINEOPLASTIC HORMONES |
616 |
9,400,640 |
| 25 MISCELLANEOUS ANTINEOPLASTICS |
108 |
2,371,625 |
| 42 ANGIOTENSIN CONVERTING ENZYME INHIBITORS |
5,394 |
74,943,275 |
| 43 ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
524 |
8,264,490 |
| 44 ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
568 |
9,235,227 |
| 45 ANTIANGINAL AGENTS |
620 |
7,952,925 |
| 46 ANTIARRHYTHMIC AGENTS |
1,886 |
27,497,413 |
| 47 BETA-ADRENERGIC BLOCKING AGENTS |
6,846 |
91,437,960 |
| 48 CALCIUM CHANNEL BLOCKING AGENTS |
5,593 |
77,366,566 |
| 49 DIURETICS |
5,644 |
77,192,733 |
| 51 MISCELLANEOUS CARDIOVASCULAR AGENTS |
51 |
459,058 |
| 53 VASODILATORS |
537 |
7,565,454 |
| 54 VASOPRESSORS |
176 |
2,911,851 |
| 55 ANTIHYPERTENSIVE COMBINATIONS |
2,181 |
28,446,549 |
| 56 ANGIOTENSIN II INHIBITORS |
5,973 |
86,102,072 |
| 58 ANALGESICS |
11,775 |
171,717,240 |
| 64 ANTICONVULSANTS |
8,646 |
127,599,859 |
| 65 ANTIEMETIC/ANTIVERTIGO AGENTS |
1,530 |
23,996,859 |
| 66 ANTIPARKINSON AGENTS |
396 |
6,009,691 |
| 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS |
4,586 |
69,228,087 |
| 71 CNS STIMULANTS |
4,120 |
77,607,236 |
| 73 MUSCLE RELAXANTS |
2,664 |
37,227,540 |
| 80 MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENT |
316 |
3,809,435 |
| 82 ANTICOAGULANTS |
2,773 |
36,231,786 |
| 83 ANTIPLATELET AGENTS |
1,325 |
17,391,827 |
| 88 ANTACIDS |
194 |
2,556,893 |
| 90 ANTIDIARRHEALS |
130 |
2,463,643 |
| 91 DIGESTIVE ENZYMES |
72 |
1,512,707 |
| 94 H2 ANTAGONISTS |
1,223 |
17,038,530 |
| 95 LAXATIVES |
708 |
10,362,066 |
| 96 MISCELLANEOUS GI AGENTS |
142 |
1,955,895 |
| 98 ADRENAL CORTICAL STEROIDS |
1,969 |
30,311,019 |
| 99 ANTIDIABETIC AGENTS |
18,879 |
273,649,020 |
| 101 SEX HORMONES |
3,372 |
66,879,634 |
| 103 THYROID HORMONES |
6,046 |
90,769,369 |
| 104 IMMUNOSUPPRESSIVE AGENTS |
602 |
10,016,511 |
| 106 ANTIDOTES |
5 |
56,836 |
| 116 IRON PRODUCTS |
779 |
10,421,728 |
| 117 MINERALS AND ELECTROLYTES |
1,557 |
20,605,240 |
| 119 VITAMINS |
3,069 |
43,729,400 |
| 120 VITAMIN AND MINERAL COMBINATIONS |
368 |
5,137,702 |
| 123 ANTIHISTAMINES |
2,105 |
29,488,754 |
| 124 ANTITUSSIVES |
333 |
4,943,959 |
| 125 BRONCHODILATORS |
7,556 |
104,314,036 |
| 127 DECONGESTANTS |
37 |
371,195 |
| 128 EXPECTORANTS |
35 |
391,105 |
| 130 RESPIRATORY INHALANT PRODUCTS |
430 |
7,094,434 |
| 132 UPPER RESPIRATORY COMBINATIONS |
285 |
4,859,030 |
| 135 ANTISEPTIC AND GERMICIDES |
62 |
1,076,655 |
| 136 DERMATOLOGICAL AGENTS |
3,388 |
53,294,960 |
| 146 MOUTH AND THROAT PRODUCTS |
79 |
1,116,941 |
| 147 OPHTHALMIC PREPARATIONS |
3,677 |
51,913,540 |
| 148 OTIC PREPARATIONS |
105 |
2,012,878 |
| 192 ANTIRHEUMATICS |
574 |
8,764,787 |
| 194 ANTIGOUT AGENTS |
1,253 |
17,111,692 |
| 219 NUTRACEUTICAL PRODUCTS |
213 |
3,026,033 |
| 220 HERBAL PRODUCTS |
97 |
1,839,772 |
| 240 LINCOMYCIN DERIVATIVES |
130 |
2,083,495 |
| 243 LEUKOTRIENE MODIFIERS |
1,728 |
25,780,477 |
| 247 NASAL PREPARATIONS |
1,701 |
26,111,192 |
| 249 ANTIDEPRESSANTS |
13,756 |
220,933,077 |
| 251 ANTIPSYCHOTICS |
1,950 |
29,469,720 |
| 264 URINARY ANTISPASMODICS |
916 |
12,504,949 |
| 266 MISCELLANEOUS GENITOURINARY TRACT AGENTS |
41 |
640,512 |
| 272 PROTON PUMP INHIBITORS |
6,522 |
95,274,573 |
| 277 5-AMINOSALICYLATES |
256 |
4,462,236 |
| 288 5-ALPHA-REDUCTASE INHIBITORS |
622 |
8,845,007 |
| 303 AGENTS FOR PULMONARY HYPERTENSION |
546 |
9,023,998 |
| 312 CHOLINERGIC AGONISTS |
63 |
668,648 |
| 313 CHOLINESTERASE INHIBITORS |
393 |
4,347,248 |
| 320 SMOKING CESSATION AGENTS |
2,090 |
35,824,248 |
| 355 FUNCTIONAL BOWEL DISORDER AGENTS |
473 |
6,574,101 |
| 397 MULTIKINASE INHIBITORS |
15 |
213,691 |
| 401 CD20 MONOCLONAL ANTIBODIES |
87 |
1,465,389 |
| 403 MTOR INHIBITORS |
20 |
683,367 |
| 409 BONE RESORPTION INHIBITORS |
728 |
9,289,761 |
| 460 PHOSPHATE BINDERS |
5 |
0 |
| 482 ANGIOTENSIN RECEPTOR BLOCKERS AND NEPRILY |
222 |
2,846,805 |
| 504 ANTIMANIC AGENTS |
193 |
3,301,040 |
| 516 NORADRENERGIC UPTAKE INHIBITORS FOR ADHD |
187 |
4,208,254 |
| 519 ALPHA-ADRENORECEPTOR ANTAGONISTS |
1,730 |
24,026,013 |
| TOTAL |
204,550 |
3,029,450,238 |
Return to list of variables
|
Back
Email Updates